Related Experiment Video
Updated: Apr 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Plasma big endothelin-1 level and the severity of new-onset stable coronary artery disease
Juan Chen1, Man-Hua Chen, Yuan-Lin Guo
1Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Cardiology, The Central Hospital of Wuhan, Wuhan, China.
Insights
Plasma big endothelin-1 (big ET-1) levels can predict the severity of coronary artery disease (CAD). Higher big ET-1 levels correlate with more severe CAD, indicating its potential as a useful clinical marker.
Area of Science:
- Cardiology
- Biomarkers
- Vascular Biology
Background:
- Coronary artery disease (CAD) severity assessment is crucial for patient management.
- Endothelin-1 (ET-1) is a potent vasoconstrictor implicated in cardiovascular diseases.
- Plasma big endothelin-1 (big ET-1) is a stable precursor to ET-1, potentially reflecting its activity.
Purpose of the Study:
- To evaluate the utility of plasma big ET-1 levels in predicting the severity of new-onset stable coronary artery disease (CAD).
- To establish the correlation between plasma big ET-1 levels and the Gensini score (GS) as a measure of CAD severity.
Main Methods:
- 963 stable CAD patients with significant stenosis were enrolled.
- Patients were stratified into low, intermediate, and high Gensini score (GS) tertiles.
- Plasma big ET-1 levels were measured and correlated with GS.
Main Results:
- Plasma big ET-1 levels significantly increased with higher Gensini score tertiles (p=0.007).
- Big ET-1 was an independent predictor of high GS (OR=2.26, p=0.009) with a positive correlation (r=0.20, p=0.000).
- An optimal cutoff of 0.34 fmol/mL for big ET-1 predicted high GS with 62.6% sensitivity and 60.3% specificity.
Conclusions:
- Plasma big ET-1 level is a valuable predictor for the severity of new-onset stable coronary artery disease.
- Elevated big ET-1 levels are associated with more severe CAD, including three-vessel disease.
- Big ET-1 shows potential as a non-invasive biomarker for assessing CAD severity.
Aim:
To investigate the usefulness of the plasma big endothelin-1 (big ET-1) level in predicting the severity of new-onset stable angiography-proven coronary artery disease (CAD).
Methods:
A total of 963 consecutive stable CAD patients with more than 50% stenosis in at least one main vessel were enrolled. The patients were classified into the three groups according to the tertile of the Gensini score (GS, low GS <20, n=300; intermediate GS 20-40, n=356 and high GS >40, n=307), and the relationship between the big ET-1 level and GS was evaluated.
Results:
The plasma levels of big ET-1 increased significantly in association with increases in the GS tertile (p=0.007). A multivariate analysis suggested that the plasma big ET-1 level was an independent predictor for a high GS (OR=2.26, 95%CI: 1.23-4.15, p=0.009), and there was a positive correlation between the big ET-1 level and the GS (r=0.20, p=0.000). The area under the receiver operating characteristic curve (AUC) for the big ET-1 level in predicting a high GS was 0.64 (95% CI 0.60-0.68, p=0.000), and the optimal cutoff value for the plasma big ET-1 level for predicting a high GS was 0.34 fmol/mL, with a sensitivity of 62.6% and specificity of 60.3%. In the high-big ET-1 level group (≥0.34 fmol/mL), there were significantly increased rates of three-vessel disease (43.6% vs. 35.4%, p=0.017) and a high GS [31 (17-54) vs. 24 (16-44), p=0.001] compared with that observed in the low-big ET-1 level group.
Conclusions:
The present findings indicate that the plasma big ET-1 level is a useful predictor of the severity of new-onset stable CAD associated with significant stenosis.
More Related Videos
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Coronary Artery Disease I: Introduction